Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin

<p>Although drug interactions with warfarin are an important cause of excessive anticoagulation, their impact on the risk of serious bleeding is unknown. We therefore performed a cohort study and a nested case-control analysis to determine the risk of serious bleeding in 4152 patients (aged 40...

Full description

Saved in:
Bibliographic Details
Main Authors: Gasse, Christiane (Author) , Hollowell, Jennifer (Author) , Meier, Christoph (Author) , Haefeli, Walter E. (Author)
Format: Article (Journal)
Language:English
Published: 2005
In: Thrombosis and haemostasis
Year: 2005, Volume: 94, Issue: 9, Pages: 537-543
ISSN:2567-689X
DOI:10.1160/TH05-03-0166
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1160/TH05-03-0166
Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1160/TH05-03-0166
Get full text
Author Notes:Christiane Gasse, Jennifer Hollowell, Christoph R. Meier, Walter E. Haefeli

MARC

LEADER 00000caa a2200000 c 4500
001 1758039647
003 DE-627
005 20230427100706.0
007 cr uuu---uuuuu
008 210518s2005 xx |||||o 00| ||eng c
024 7 |a 10.1160/TH05-03-0166  |2 doi 
035 |a (DE-627)1758039647 
035 |a (DE-599)KXP1758039647 
035 |a (OCoLC)1341413143 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gasse, Christiane  |d 1969-  |e VerfasserIn  |0 (DE-588)122686691  |0 (DE-627)706000994  |0 (DE-576)293380759  |4 aut 
245 1 0 |a Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin  |c Christiane Gasse, Jennifer Hollowell, Christoph R. Meier, Walter E. Haefeli 
264 1 |c 2005 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online: 07. Dezember 2017 
500 |a Gesehen am 18.05.2021 
520 |a <p>Although drug interactions with warfarin are an important cause of excessive anticoagulation, their impact on the risk of serious bleeding is unknown. We therefore performed a cohort study and a nested case-control analysis to determine the risk of serious bleeding in 4152 patients (aged 40-84 years) with nonvalvular atrial fibrillation (AF) taking long-term warfarin (>3 months). The study population was drawn from the UK General Practice Research Database. More than half (58%) of eligible patients used potentially interacting drugs during continuous warfarin treatment. Among 45 identified cases of incident idiopathic bleeds (resulting in hospitalisation within 30 days or death within 7 days) and 143 matched controls, more cases than controls took ≥1 potentially interacting drug within the preceding 30 days (62.2% vs. 35.7%) and used >4 drugs (polypharmacy) within the preceding 90 days (80.0% vs. 66.4%). Conditional logistic regression analysis yielded an odds ratio (OR) of 3.4 (95% confidence interval [CI]: 1.4-8.5) for the risk of serious bleeding in patients treated with warfarin and ≥1 drugs potentially increasing the effect of warfarin vs. warfarin alone adjusted for polypharmacy, diabetes, hypertension, heart failure, and thyroid disease; the adjusted OR for the combined use of warfarin and aspirin vs. warfarin alone was 4.5 (95% CI: 1.1-18.1). We conclude that concurrent use of potentially interacting drugs with warfarin is associated with a 3 to 4.5-fold increased risk of serious bleeding in long-term warfarin users.</p> 
700 1 |a Hollowell, Jennifer  |e VerfasserIn  |4 aut 
700 1 |a Meier, Christoph  |e VerfasserIn  |0 (DE-588)1150809973  |0 (DE-627)1011060051  |0 (DE-576)49727096X  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
773 0 8 |i Enthalten in  |t Thrombosis and haemostasis  |d Stuttgart : Thieme, 1976  |g 94(2005), 9, Seite 537-543  |h Online-Ressource  |w (DE-627)302723188  |w (DE-600)1492370-1  |w (DE-576)079877362  |x 2567-689X  |7 nnas  |a Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin 
773 1 8 |g volume:94  |g year:2005  |g number:9  |g pages:537-543  |g extent:7  |a Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin 
856 4 0 |u https://doi.org/10.1160/TH05-03-0166  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.thieme-connect.de/DOI/DOI?10.1160/TH05-03-0166  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210518 
993 |a Article 
994 |a 2005 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 4  |y j 
999 |a KXP-PPN1758039647  |e 3929268221 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"2005","dateIssuedKey":"2005"}],"recId":"1758039647","type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin","title_sort":"Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin"}],"name":{"displayForm":["Christiane Gasse, Jennifer Hollowell, Christoph R. Meier, Walter E. Haefeli"]},"physDesc":[{"extent":"7 S."}],"note":["Online: 07. Dezember 2017","Gesehen am 18.05.2021"],"person":[{"given":"Christiane","family":"Gasse","display":"Gasse, Christiane","role":"aut"},{"family":"Hollowell","given":"Jennifer","display":"Hollowell, Jennifer","role":"aut"},{"role":"aut","display":"Meier, Christoph","given":"Christoph","family":"Meier"},{"role":"aut","display":"Haefeli, Walter E.","family":"Haefeli","given":"Walter E."}],"language":["eng"],"relHost":[{"disp":"Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarinThrombosis and haemostasis","recId":"302723188","type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"1976","publisher":"Thieme ; Schattauer","dateIssuedDisp":"1976-","publisherPlace":"Stuttgart ; Stuttgart"}],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 15.06.2018"],"part":{"text":"94(2005), 9, Seite 537-543","extent":"7","issue":"9","volume":"94","year":"2005","pages":"537-543"},"id":{"eki":["302723188"],"doi":["10.1055/s-00035024"],"zdb":["1492370-1"],"issn":["2567-689X"]},"pubHistory":["35.1976 -"],"title":[{"subtitle":"journal of the International Society on Thrombosis and Haemostasis","title":"Thrombosis and haemostasis","title_sort":"Thrombosis and haemostasis"}],"language":["eng"]}],"id":{"doi":["10.1160/TH05-03-0166"],"eki":["1758039647"]}} 
SRT |a GASSECHRISDRUGINTERA2005